menu search

EW / Edwards Lifesciences: Rising Dominance In Structural Heart Disease

Edwards Lifesciences: Rising Dominance In Structural Heart Disease
Edwards Lifesciences is the global leader in medical devices for structural heart disease and critical care monitoring. Their Transcatheter Aortic Valve Replacement technology dominates the market and is expected to continue its leading position. EW's growth is driven by the under-penetrated TAVR market and advancements in surgical structural heart and critical care therapies. Read More
Posted: Aug 21 2023, 07:01
Author Name: Seeking Alpha
Views: 110151

EW News  

ITGR or EW: Which Is the Better Value Stock Right Now?

By Zacks Investment Research
October 30, 2023

ITGR or EW: Which Is the Better Value Stock Right Now?

Investors with an interest in Medical - Instruments stocks have likely encountered both Integer (ITGR) and Edwards Lifesciences (EW). But which of the more_horizontal

Why Edwards Lifesciences Stock Plummeted Today

By The Motley Fool
October 26, 2023

Why Edwards Lifesciences Stock Plummeted Today

The maker of medical devices posted third-quarter results that broadly met analyst expectations. That wasn't the reason for the resulting investor sel more_horizontal

Edwards Lifesciences (EW) Q3 Earnings Match Mark, Margins Dip

By Zacks Investment Research
October 26, 2023

Edwards Lifesciences (EW) Q3 Earnings Match Mark, Margins Dip

Edwards Lifesciences (EW) TMTT performance benefits from the accelerated adoption of the differentiated PASCAL precision platform in the third quarter more_horizontal

Edwards Lifesciences Corporation (EW) Q3 2023 Earnings Call Transcript

By Seeking Alpha
October 26, 2023

Edwards Lifesciences Corporation (EW) Q3 2023 Earnings Call Transcript

Edwards Lifesciences Corporation (NYSE:EW ) Q3 2023 Earnings Conference Call October 25, 2023 5:00 PM ET Company Participants Mark Wilterding - SVP, I more_horizontal

Edwards Lifesciences (EW) Q3 Earnings Match Estimates

By Zacks Investment Research
October 25, 2023

Edwards Lifesciences (EW) Q3 Earnings Match Estimates

Edwards Lifesciences (EW) came out with quarterly earnings of $0.59 per share, in line with the Zacks Consensus Estimate. This compares to earnings of more_horizontal

Edwards Lifesciences quarterly sales jump on robust demand for heart devices

By Reuters
October 25, 2023

Edwards Lifesciences quarterly sales jump on robust demand for heart devices

Edwards Lifesciences Corp on Wednesday reported a 12% rise in third-quarter sales, helped by strong demand for the company's artificial heart valves a more_horizontal

5 Large-Cap Stocks to Buy Ahead of Q3 Earnings This Week

By Zacks Investment Research
October 25, 2023

5 Large-Cap Stocks to Buy Ahead of Q3 Earnings This Week

We have narrowed our search to five large-cap stocks that are set to declare third-quarter earnings results this week. These are: EW, VICI, VMC, GLPI, more_horizontal

What's in Store for Edwards Lifesciences (EW) in Q3 Earnings?

By Zacks Investment Research
October 23, 2023

What's in Store for Edwards Lifesciences (EW) in Q3 Earnings?

Outside the United States, Edwards Lifesciences (EW) TAVR sales growth will likely be driven by broad-based adoption of the SAPIEN platform. more_horizontal


Search within

Pages Search Results: